These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16372060)

  • 1. Pharmacogenetics of epilepsy: one step forward?
    Sills GJ
    Epilepsy Curr; 2005; 5(6):236-8. PubMed ID: 16372060
    [No Abstract]   [Full Text] [Related]  

  • 2. A step forward in methotrexate pharmacogenetics.
    Moya P; Corominas H; Salazar J; Díaz-Torné C
    Reumatol Clin; 2017; 13(5):305. PubMed ID: 28110875
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential of pharmacogenetics in the treatment of epilepsy.
    Depondt C
    Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.
    Depondt C; Shorvon SD
    Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on pharmacogenetics in epilepsy: a brief review.
    Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ
    Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of pharmacogenetics on the drug therapy of epilepsy].
    Zang LL; Wang L; Wu Y
    Zhonghua Er Ke Za Zhi; 2011 Aug; 49(8):599-602. PubMed ID: 22093423
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epilepsy pharmacogenetics : science or fiction?].
    Depondt C
    Med Sci (Paris); 2013 Feb; 29(2):189-93. PubMed ID: 23452606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and personalised medicine: maintain a critical approach.
    Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy pharmacogenetics.
    Kasperaviciūte D; Sisodiya SM
    Pharmacogenomics; 2009 May; 10(5):817-36. PubMed ID: 19450130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin pharmacogenomics: a big step forward for individualized medicine: enlightened dosing of warfarin.
    Elias DJ; Topol EJ
    Eur J Hum Genet; 2008 May; 16(5):532-4. PubMed ID: 18301451
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetics and the treatment of epilepsy: what do we know?
    Božina N; Sporiš IŠ; Božina T; Klarica-Domjanović I; Tvrdeić A; Sporiš D
    Pharmacogenomics; 2019 Oct; 20(15):1093-1101. PubMed ID: 31588875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics?
    Cascorbi I
    Clin Pharmacol Ther; 2010 Jan; 87(1):15-8. PubMed ID: 20019695
    [No Abstract]   [Full Text] [Related]  

  • 13. Defining the clinical role of pharmacogenetics in antiepileptic drug therapy.
    Dlugos DJ; Buono RJ; Ferraro TN
    Pharmacogenomics J; 2006; 6(6):357-9. PubMed ID: 16505830
    [No Abstract]   [Full Text] [Related]  

  • 14. Newly diagnosed epilepsy and pharmacogenomics research: a step in the right direction?
    Johnson MR; Tan NC; Kwan P; Brodie MJ
    Epilepsy Behav; 2011 Sep; 22(1):3-8. PubMed ID: 21420909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.
    Schmidt D; Löscher W
    Epilepsia; 2005 Jun; 46(6):858-77. PubMed ID: 15946327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics education: 10 years of experience at Tel Aviv University.
    Gurwitz D
    Pharmacogenomics; 2010 May; 11(5):647-9. PubMed ID: 20415554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in epilepsy.
    Balestrini S; Sisodiya SM
    Neurosci Lett; 2018 Feb; 667():27-39. PubMed ID: 28082152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance in epilepsy: a pharmacogenomic update.
    Tate SK; Sisodiya SM
    Expert Opin Pharmacother; 2007 Jul; 8(10):1441-9. PubMed ID: 17661727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics.
    Holmes GL
    Epilepsy Res; 2002 Jun; 50(1-2):41-54. PubMed ID: 12151116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of genetics and ethnicity in epilepsy management.
    Scheffer IE
    Acta Neurol Scand Suppl; 2005; 181():47-51. PubMed ID: 16238709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.